Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 13;9(5):ofac013.
doi: 10.1093/ofid/ofac013. eCollection 2022 May.

Triage by PAX1 and ZNF582 Methylation in Women With Cervical Intraepithelial Neoplasia Grade 3: A Multicenter Case-Control Study

Affiliations

Triage by PAX1 and ZNF582 Methylation in Women With Cervical Intraepithelial Neoplasia Grade 3: A Multicenter Case-Control Study

Kun Fu et al. Open Forum Infect Dis. .

Abstract

Background: The colposcopy-conization inconsistency is common in women with cervical intraepithelial neoplasia grade 3 (CIN3). No adequate method has been reported to identify the final pathology of conization. In this study, we explored the ability of PAX1 and ZNF582 methylation to predict the pathological outcome of conization in advance.

Methods: This was a multicenter study and included 277 histologically confirmed CIN3 women who underwent cold knife conization (CKC) from January 2019 to December 2020. The methylation levels of PAX1 (PAX1m) and ZNF582 (ZNF582m) were determined by quantitative methylation-specific polymerase chain reaction (qMSP) and expressed in ΔCp. Receiver operating characteristic curves were used to evaluate predictive accuracy.

Results: The final pathological results in 48 (17.33%) patients were inflammation or low-grade squamous intraepithelial lesion (LSIL), 190 (68.59%) were high-grade squamous intraepithelial lesion (HSIL), and 39 (14.08%) were squamous cervical cancer (SCC). PAX1m and ZNF582m increased as lesions progressed from inflammation/LSIL, HSIL, to SCC. PAX1 and ZNF582 methylation yielded better prediction performance compared with common screening strategies, whether individually or combined. A 4.33-fold increase in the probability of inflammation/LSIL was observed in patients with lower ZNF582 methylation levels (ΔCpZNF582 ≥ 19.18). A 6.53-fold increase in SCC risk was observed in patients with elevated ZNF582 methylation (ΔCpZNF582 < 7.09).

Conclusions: DNA methylation would be an alternative screening method to triage and predict the final outcome of conization in CIN3 cases.

Keywords: DNA methylation; PAX1; ZNF582; cervical intraepithelial neoplasia grade 3; triage.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The flowchart of patients. Abbreviations: AIS, adenocarcinoma in situ; CIN, cervical intraepithelial neoplasia; SCC, squamous cervical cancer.
Figure 2.
Figure 2.
The methylation value of PAX1 and ZNF582 in patients with different clinical outcomes. A, ΔCpPAX1 according to different grades of lesions. B, ΔCpZNF582 according to different grades of lesions. The dotted line corresponds to the threshold for distinguishing inflammation/LSIL/HSIL from SCC, and the dashed line corresponds to the threshold for distinguishing inflammation/LSIL from HSIL/SCC. Statistically significant (P < .05). Abbreviations: CIN, cervical intraepithelial neoplasia; hrHPV, high-risk HPV; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; SCC, squamous cervical cancer.
Figure 3.
Figure 3.
Receiver operating characteristic curves for the performance of PAX1, ZNF582 methylation, and the combination model of the 2 genes. A, inflammation/LSIL vs HSIL/SCC. B, inflammation/LSIL/HSIL vs SCC. C, inflammation/LSIL vs SCC. Abbreviations: AUC, area under the receiver operating characteristic curve; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; SCC, squamous cervical cancer.

References

    1. Practice Bulletin N. 157: cervical cancer screening and prevention. Obstet Gynecol 2016; 127:e1–20. - PubMed
    1. Perkins RB, Guido RS, Castle PE, et al. . 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020; 24:102–31. - PMC - PubMed
    1. Giannella L, Mfuta K, Gardini G, et al. . High-grade CIN on cervical biopsy and predictors of the subsequent cone histology results in women undergoing immediate conization. Eur J Obstet Gynecol Reprod Biol 2015; 186:68–74. - PubMed
    1. Jung Y, Lee AR, Lee SJ, et al. . Clinical factors that affect diagnostic discrepancy between colposcopically directed biopsies and loop electrosurgical excision procedure conization of the uterine cervix. Obstet Gynecol Sci 2018; 61:477–88. - PMC - PubMed
    1. Kyrgiou M, Athanasiou A, Kalliala IEJ, et al. . Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease. Cochrane Database Syst Rev 2017; 11:CD012847. - PMC - PubMed

LinkOut - more resources